# Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region

> Research article (Cardiovascular Diabetology, 2021) · cited 26× · AI/ML

**Wikidata**: [openalex:W3207947340](https://www.wikidata.org/wiki/openalex:W3207947340)  
**Source**: https://4ort.xyz/entity/cost-effectiveness-evaluation-of-add-on-dapagliflozin-for-heart-failure-with-reduced-ejection-fraction-from-perspective-